Form 4 for QNRX Quoin Pharmaceuticals Ltd.
Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-09 · accession 0001104659-24-098940 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-11 | 2024-09-09+ | QNRX | Dunn Gordon | CFO | P - Purchase | $0.8042 | +28.9K | 28.9K | New | +$23.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-09-10 | P | A | 10,000 | $0.91 | 18,856 | D | — | — | (F1) Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer. |
| 2 | Common | Ordinary Shares | 2024-09-09 | P | A | 4,000 | $0.8 | 8,856 | D | — | — | (F1) Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer. |
| 3 | Common | Ordinary Shares | 2024-09-09 | P | A | 4,000 | $0.78 | 4,856 | D | — | — | (F1) Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer. |
| 4 | Common | Ordinary Shares | 2024-09-09 | P | A | 856 | $0.8 | 856 | D | — | — | (F1) Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer. |
| 5 | Common | Ordinary Shares | 2024-09-10 | P | A | 10,000 | $0.71 | 28,856 | D | — | — | (F1) Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer. |